ATTENTION Queenslanders interested in immune-based Cancer Therapies: Cancer Immunotherapy Week Brisbane
QIMR Berghofer Medical Research Institute is hosting Immunotherapy week: Get updated about Immunotherapies. Next week QIMR presents a series of lectures about the latest developments in Cancer Immune therapies.
Scientists at the QIMR Berghofer Medical Research Institute have used immunotherapy to make a major breakthrough in the treatment of the aggressive brain cancer Glioblastoma Multiforme (GBM). There will be a presentation on Tuesday evening and other presentations throughout the week.
CLICK HERE FOR MORE INFORMATION
Later this week on Navigating the Cancer Maze I will be interviewing…Professor Rajiv Khanna a leading researcher at The QIMR Berghofer Medical Research Institute, Brisbane, Australia; a world progressive translational research institute focused on cancer, infectious diseases, mental health and a range of complex diseases. Professor Khanna has been researching immunotherapies and has had a major breakthrough in the treatment of the aggressive brain cancer Glioblastoma Multiforme (GBM). Professor Khanna developed a technique to modify the patients’ T-cells in the laboratory, effectively “train” them to attack the virus, and then return them to the patient’s body. When the killer T-cells destroyed the virus, they also destroyed the cancer. “It’s becoming increasingly clear that immunotherapy – manipulating a person’s own immune system – is a rich new frontier for cancer treatment,” Professor Khanna said. Be informed about the answer to cancer. Support Immunotherapy week- Brisbane Qld. More info at http://www.qimrberghofer.edu.au/
All shows are available in the content Library at Navigating the Cancer Maze on The VoiceAmerica Variety Channel for on-demand and pod cast download. The Grace Gawler Institute is a not for profit health promotion charity providing global access to free information for cancer patients about the latest in cancer information and treatments from experts, patients, caregivers and researchers.